U.S. stocks
ABBV
Report not generated
AbbVie
Skyrizi and Rinvoq
Why these companies
Selection basis
Representative companies
Immunology & inflammation drugs leader list
U.S. stocks
JNJ
Report not generated
Johnson & Johnson
Tremfya and Stelara
U.S. stocks
ARGX
Report not generated
argenx
FcRn antibody platform (ADR)
U.S. stocks
IMVT
Report not generated
Immunovant
Clinical-stage FcRn inhibitors
U.S. stocks
INCY
Report not generated
Incyte
JAK inhibitors and dermatology drugs
A standard report for a new stock is free for the first generation. Professional valuation is paid and uses one credit. Existing public reports are free to view.
Sources
Industry and company sources
This page is a research directory. “Representative leader” is not an official designation, a return forecast or trading advice. Valuations and reports may contain errors or outdated information; verify against company filings and authoritative sources.